David D. Meek, Chief Commercial Officer at ENDOCYTE INC (ECYT), sold 10,000 shares at $15.50 ($155K) on 2013-09-12, disclosed to the SEC on 2013-09-16.
Open-market sale of $155k ECYT by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| QURE | SELL | 2024-06-17 | $11K | — | Filing → |
| QURE | SELL | 2023-06-20 | $43K | — | Filing → |
| QURE | SELL | 2023-03-01 | $8K | — | Filing → |